Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butenafine HCl 1% Repeated Insult Patch Test
NCT04531540Phase 3Completed
- Sponsor
- Bayer
- Start
- Sep 2013
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butenafine in tinea pedis, tinea corporis, Tinea cruris (TC), sponsored by Bayer. Started Sep 2013; status: completed.
02
Drugs
butenafine
03
Conditions
tinea pedistinea corporisTinea cruris (TC)
Beyond the preview
Go deeper on NCT04531540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04531540.